Cargando…

Anticoagulation in COVID-19: DDI Perspective

Detalles Bibliográficos
Autores principales:	Khiali, Sajad, Entezari-Maleki, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498959/ https://www.ncbi.nlm.nih.gov/pubmed/32936672 http://dx.doi.org/10.1177/1076029620959457

Ejemplares similares

Tocilizumab in COVID-19 management: addressing time of starting treatment
por: Khiali, Sajad, et al.
Publicado: (2023)

Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
por: Rezagholizadeh, Afra, et al.
Publicado: (2021)

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
por: Khani, Elnaz, et al.
Publicado: (2021)

Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
por: Khiali, Sajad, et al.
Publicado: (2022)

Isotretinoin; A review on the Utilization Pattern in Pregnancy
por: Khiali, Sajad, et al.
Publicado: (2018)

SARS-CoV-2 and probable lung cancer risk
por: Khiali, Sajad, et al.
Publicado: (2022)

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial
por: Khiali, Sajad, et al.
Publicado: (2023)

Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDI
por: Jones, Nicholas S., et al.
Publicado: (2019)

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
por: Khani, Elnaz, et al.
Publicado: (2022)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Mechanisms of stroke and the role of anticoagulants in COVID-19
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Covid-19-induced coagulopathy and observed benefits with anticoagulation
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

Managing Anticoagulation for COVID-19-Related Lung Transplantation
por: Fox, W. Everett, et al.
Publicado: (2023)

A commentary on “Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?” (Int J Surg 2022;103:106705)
por: Khani, Elnaz, et al.
Publicado: (2022)

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2020)

COVID-19 and anticoagulant based therapeutics: Approach with great promise
por: Sharma, Varun Kumar, et al.
Publicado: (2021)

Transient endothelial injury and release of lupus anticoagulant in COVID-19
por: Trimaille, Antonin, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
por: McGlynn, Fergal, et al.
Publicado: (2020)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

Lupus anticoagulant hypoprothrombinemia syndrome - could it be a sequelae of COVID-19?
por: Stjepovic, Nusa Matijasic, et al.
Publicado: (2023)

Ddi1 is a ubiquitin-dependent protease
por: Yip, Matthew C. J., et al.
Publicado: (2020)

Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy
por: Belen-Apak, F. Burcu, et al.
Publicado: (2020)

Consideration Needed for early Anticoagulation Following Intravenous tPA in Patients with COVID-19
por: Jimenez, Angelo, et al.
Publicado: (2021)

Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19
por: López Reboiro, Manuel Lorenzo, et al.
Publicado: (2021)

Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 – The role of anti-Xa monitoring
por: Kofteridis, Diamantis P., et al.
Publicado: (2021)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2022)

Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)

Fundus Examination to Guide Anticoagulation Therapy in Suspected COVID-19 in a Critical Care Unit
por: Saha, Rini, et al.
Publicado: (2021)

Use of anticoagulants in patients with COVID-19: an update of a living systematic review and meta-analysis
por: Batista, Diane R, et al.
Publicado: (2023)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021)

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19
por: Voicu, Sebastian, et al.
Publicado: (2021)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’
por: Khani, Elnaz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a5tvjov8v91du8f38qhm3u8t1j